Your browser doesn't support javascript.
loading
Spike and nsp6 are key determinants of SARS-CoV-2 Omicron BA.1 attenuation.
Chen, Da-Yuan; Chin, Chue Vin; Kenney, Devin; Tavares, Alexander H; Khan, Nazimuddin; Conway, Hasahn L; Liu, GuanQun; Choudhary, Manish C; Gertje, Hans P; O'Connell, Aoife K; Adams, Scott; Kotton, Darrell N; Herrmann, Alexandra; Ensser, Armin; Connor, John H; Bosmann, Markus; Li, Jonathan Z; Gack, Michaela U; Baker, Susan C; Kirchdoerfer, Robert N; Kataria, Yachana; Crossland, Nicholas A; Douam, Florian; Saeed, Mohsan.
Afiliação
  • Chen DY; Department of Biochemistry, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA.
  • Chin CV; National Emerging Infectious Diseases Laboratories, Boston University, Boston, MA, USA.
  • Kenney D; Department of Biochemistry, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA.
  • Tavares AH; National Emerging Infectious Diseases Laboratories, Boston University, Boston, MA, USA.
  • Khan N; National Emerging Infectious Diseases Laboratories, Boston University, Boston, MA, USA.
  • Conway HL; Department of Microbiology, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA.
  • Liu G; Department of Biochemistry, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA.
  • Choudhary MC; National Emerging Infectious Diseases Laboratories, Boston University, Boston, MA, USA.
  • Gertje HP; Department of Biochemistry, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA.
  • O'Connell AK; National Emerging Infectious Diseases Laboratories, Boston University, Boston, MA, USA.
  • Adams S; Department of Biochemistry, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA.
  • Kotton DN; National Emerging Infectious Diseases Laboratories, Boston University, Boston, MA, USA.
  • Herrmann A; Florida Research and Innovation Center, Cleveland Clinic, Port St. Lucie, FL, USA.
  • Ensser A; Brigham and Women's Hospital, Boston, MA, USA.
  • Connor JH; Harvard Medical School, Cambridge, MA, USA.
  • Bosmann M; National Emerging Infectious Diseases Laboratories, Boston University, Boston, MA, USA.
  • Li JZ; National Emerging Infectious Diseases Laboratories, Boston University, Boston, MA, USA.
  • Gack MU; National Emerging Infectious Diseases Laboratories, Boston University, Boston, MA, USA.
  • Baker SC; Department of Microbiology, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA.
  • Kirchdoerfer RN; Center for Regenerative Medicine of Boston University and Boston Medical Center, Boston, MA, USA.
  • Kataria Y; The Pulmonary Center and Department of Medicine, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA.
  • Crossland NA; Institute of Clinical and Molecular Virology, University Hospital Erlangen, Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Douam F; Institute of Clinical and Molecular Virology, University Hospital Erlangen, Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Saeed M; National Emerging Infectious Diseases Laboratories, Boston University, Boston, MA, USA.
Nature ; 615(7950): 143-150, 2023 03.
Article em En | MEDLINE | ID: mdl-36630998

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Virulência / Fatores de Virulência / Glicoproteína da Espícula de Coronavírus / Proteínas do Nucleocapsídeo de Coronavírus / SARS-CoV-2 / COVID-19 Limite: Animals / Humans Idioma: En Revista: Nature Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Virulência / Fatores de Virulência / Glicoproteína da Espícula de Coronavírus / Proteínas do Nucleocapsídeo de Coronavírus / SARS-CoV-2 / COVID-19 Limite: Animals / Humans Idioma: En Revista: Nature Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos